Suchergebnisse - "Murray, Daniel D"

PubPharm (9)

1

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

enthalten in: The Journal of infectious diseases | 2024

von Jensen, T. | Grandits, G. | Jain, M. | +131

2

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO) : a randomised, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2023

von Brown, S. | Barkauskas, C. | Grund, B. | +185

CommentIn: Lancet Respir Med. 2023 Sep;11(9):759-760. - PMID 37348523

3

Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19 : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2022

von ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group | Ginde, A. | Paredes, R. | +98

CommentIn: Lancet Respir Med. 2022 Oct;10(10):928-930. - PMID 35817073

4

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial

enthalten in: Annals of internal medicine | 2022

von ACTIV-3/TICO Study Group | Barkauskas, C. | Mylonakis, E. | +98

CommentIn: Ann Intern Med. 2023 Feb;176(2):eL220455. - PMID 36802894

5

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial

enthalten in: Annals of internal medicine | 2022

von ACTIV-3/TICO Bamlanivimab Study Group | Lundgren, J. | Grund, B. | +151

6

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC) : a double-blind, placebo-controlled, phase 3, randomised trial

enthalten in: Lancet (London, England) | 2022

von ITAC (INSIGHT 013) Study Group | Polizzotto, M. | Nordwall, J. | +86

7

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

enthalten in: The New England journal of medicine | 2021

von ACTIV-3/TICO LY-CoV555 Study Group | Lundgren, J. | Grund, B. | +144

CommentIn: N Engl J Med. 2021 Feb 3;:. - PMID 33534967

8

Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial

enthalten in: American journal of hypertension | 2020

von Ghazi, L. | Baker, J. | Sharma, S. | +6

9

Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial

enthalten in: The Journal of infectious diseases | 2019

von Ekenberg, C. | Tang, M. | Zucco, A. | +16

1
[1]